ENST00000441024.6:c.4629delT

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBA1

The ENST00000441024.6(CNOT1):​c.4629delT​(p.Leu1544CysfsTer11) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.25 in 1,322,598 control chromosomes in the GnomAD database, including 8,091 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 4716 hom., cov: 21)
Exomes 𝑓: 0.25 ( 3375 hom. )

Consequence

CNOT1
ENST00000441024.6 frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0160

Publications

13 publications found
Variant links:
Genes affected
CNOT1 (HGNC:7877): (CCR4-NOT transcription complex subunit 1) Enables armadillo repeat domain binding activity; molecular adaptor activity; and nuclear receptor binding activity. Contributes to poly(A)-specific ribonuclease activity. Involved in several processes, including negative regulation of signal transduction; positive regulation of cytoplasmic mRNA processing body assembly; and regulation of gene expression. Located in P-body and cytosol. Part of CCR4-NOT complex. Implicated in holoprosencephaly. [provided by Alliance of Genome Resources, Apr 2022]
CNOT1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • holoprosencephaly 12 with or without pancreatic agenesis
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
  • Vissers-Bodmer syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0058 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 16-58543411-GA-G is Benign according to our data. Variant chr16-58543411-GA-G is described in ClinVar as [Benign]. Clinvar id is 402549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.395 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNOT1NM_016284.5 linkc.4434+195delT intron_variant Intron 31 of 48 ENST00000317147.10 NP_057368.3 A5YKK6-1
CNOT1NM_206999.3 linkc.4629delT p.Leu1544CysfsTer11 frameshift_variant Exon 31 of 31 NP_996882.1 A5YKK6-4
CNOT1NM_001265612.2 linkc.4419+195delT intron_variant Intron 31 of 48 NP_001252541.1 A5YKK6-2
CNOT1NR_049763.2 linkn.4692+195delT intron_variant Intron 31 of 49

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNOT1ENST00000317147.10 linkc.4434+195delT intron_variant Intron 31 of 48 1 NM_016284.5 ENSP00000320949.5 A5YKK6-1

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
36428
AN:
129714
Hom.:
4707
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.200
Gnomad AMI
AF:
0.293
Gnomad AMR
AF:
0.381
Gnomad ASJ
AF:
0.270
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.367
Gnomad FIN
AF:
0.342
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.282
Gnomad OTH
AF:
0.276
GnomAD2 exomes
AF:
0.340
AC:
23153
AN:
68028
AF XY:
0.338
show subpopulations
Gnomad AFR exome
AF:
0.240
Gnomad AMR exome
AF:
0.383
Gnomad ASJ exome
AF:
0.331
Gnomad EAS exome
AF:
0.374
Gnomad FIN exome
AF:
0.352
Gnomad NFE exome
AF:
0.328
Gnomad OTH exome
AF:
0.333
GnomAD4 exome
AF:
0.247
AC:
294644
AN:
1192822
Hom.:
3375
Cov.:
0
AF XY:
0.248
AC XY:
144263
AN XY:
582162
show subpopulations
African (AFR)
AF:
0.169
AC:
4234
AN:
25078
American (AMR)
AF:
0.339
AC:
6597
AN:
19446
Ashkenazi Jewish (ASJ)
AF:
0.241
AC:
4548
AN:
18900
East Asian (EAS)
AF:
0.308
AC:
9987
AN:
32424
South Asian (SAS)
AF:
0.294
AC:
17341
AN:
59004
European-Finnish (FIN)
AF:
0.279
AC:
11567
AN:
41392
Middle Eastern (MID)
AF:
0.218
AC:
995
AN:
4560
European-Non Finnish (NFE)
AF:
0.241
AC:
226952
AN:
942696
Other (OTH)
AF:
0.252
AC:
12423
AN:
49322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
13767
27534
41302
55069
68836
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9060
18120
27180
36240
45300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.281
AC:
36455
AN:
129776
Hom.:
4716
Cov.:
21
AF XY:
0.289
AC XY:
18091
AN XY:
62542
show subpopulations
African (AFR)
AF:
0.200
AC:
6828
AN:
34220
American (AMR)
AF:
0.381
AC:
5123
AN:
13430
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
860
AN:
3180
East Asian (EAS)
AF:
0.410
AC:
1897
AN:
4626
South Asian (SAS)
AF:
0.367
AC:
1576
AN:
4292
European-Finnish (FIN)
AF:
0.342
AC:
2509
AN:
7344
Middle Eastern (MID)
AF:
0.172
AC:
41
AN:
238
European-Non Finnish (NFE)
AF:
0.282
AC:
16912
AN:
59944
Other (OTH)
AF:
0.279
AC:
491
AN:
1758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1255
2510
3765
5020
6275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.105
Hom.:
176

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency -

not provided Benign:1
Jan 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.016
Mutation Taster
=183/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5817153; hg19: chr16-58577315; COSMIC: COSV55312370; COSMIC: COSV55312370; API